Skip to main content

Login Register ›

Email address

Password

Forgot your password?

New? Register

sbv IMPROVER
Microbiomics
SysTox
Network Verification
Diagnostic Signature
Species Translation

Overview
Participate
Awards
BELIEF
Previous phases
Resources
Tutorials
Challenge Rules
Symposium 2018

Navigation

Site Navigation

Home
Network Verification
Tutorials
Tutorials
Introduction to Biological Network Models

Introduction to Biological Network Models

Introduction to Biological Network Models

This video gives an introduction to biological network models.

Tutorials
Webinars

Share this page

About us

FAQs
Contact us
Media

Legal Information

Summary of Terms
Terms of Use
Privacy Policy

About sbv IMPROVER

The sbv IMPROVER project, the websites and the Symposia are part of a collaborative project designed to enable scientists to learn about and contribute to the development of a new crowd sourcing method for verification of scientific data and results. The project is led and funded by Philip Morris International. The current challenges, website and biological network models were developed and are maintained as part of a collaboration with Selventa, Douglas Connect, SBX, OrangeBus and ADS. For more information on Philip Morris International’s research, please visit www.pmiscience.com.

Reduced Risk Products (RRPs)

*Reduced Risk Products (“RRPs”) is the term we use to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. PMI’s RRPs are in various stages of development and commercialization, and we are conducting extensive and rigorous scientific studies to determine whether we can support claims for such products of reduced exposure to harmful and potentially harmful constituents in smoke, and ultimately claims of reduced disease risk, when compared to smoking cigarettes. Before making any such claims, we will rigorously evaluate the full set of data from the relevant scientific studies to determine whether they substantiate reduced exposure or risk. Any such claims may also be subject to government review and authorization, as is the case in the USA today.